IMCC · NASDAQ
IM Cannabis (IMCC) Stock Price & Fundamentals
IM Cannabis (IMCC) closed at $491.47 on Oct 9, 2026, down 0.70% from the previous close of $494.95.
Share price, past year
1Y +20.43%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $491.47 |
| Sep 30, 2026 | $501.41 |
| Aug 31, 2026 | $474.15 |
| Jul 31, 2026 | $492.08 |
| Jun 30, 2026 | $475.37 |
| May 29, 2026 | $469.20 |
| Apr 30, 2026 | $483.75 |
| Mar 31, 2026 | $474.24 |
| Feb 27, 2026 | $457.34 |
| Jan 30, 2026 | $422.04 |
| Dec 31, 2025 | $423.61 |
| Nov 28, 2025 | $397.33 |
| Oct 31, 2025 | $417.23 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 5.9M
- Dividend yield
- —
- 52-week range
- $395.18 – $505.97
Market cap, P/E and dividend yield aren't shown for IM Cannabis yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US, and report in Canadian dollars.
Financials
IM Cannabis reported revenue of CA$54.73M for fiscal 2025, up 1.30% from fiscal 2024.
Figures are in Canadian dollars (CAD), as IM Cannabis reports them to the SEC.
IM Cannabis reported a net loss of CA$11.32M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 7 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | CA$54.73M | +1.3% | −CA$11.32M | −20.7% | — | CA$4.70M |
| FY2024ended Dec 31, 2024 | CA$54.03M | +10.7% | −CA$10.59M | −19.6% | −CA$4.51 | −CA$1.23M |
| FY2023ended Dec 31, 2023 | CA$48.80M | −10.2% | −CA$9.50M | −19.5% | −CA$4.45 | −CA$8.66M |
| FY2022ended Dec 31, 2022 | CA$54.34M | +59.6% | −CA$188.89M | −347.6% | −CA$161.88 | −CA$14.20M |
| FY2021ended Dec 31, 2021 | CA$34.05M | +114.3% | −CA$17.76M | −52.2% | −CA$6.70 | −CA$38.95M |
| FY2020ended Dec 31, 2020 | CA$15.89M | +75.1% | −CA$28.70M | −180.6% | −CA$1.90 | −CA$10.54M |
| FY2019ended Dec 31, 2019 | CA$9.07M | — | −CA$7.29M | −80.4% | — | −CA$7.51M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2025ended Jun 30, 2025 | CA$12.70M | −CA$309.00K | −CA$0.09 |
| Q2 FY2024ended Jun 30, 2024 | CA$14.75M | −CA$3.03M | −CA$1.36 |
| Q2 FY2023ended Jun 30, 2023 | CA$13.21M | −CA$3.46M | −CA$0.26 |
| Q2 FY2022ended Jun 30, 2022 | CA$12.70M | −CA$18.67M | −CA$3.12 |
| Q2 FY2021ended Jun 30, 2021 | CA$11.11M | −CA$4.63M | −CA$0.23 |
Earnings
IM Cannabis lost CA$0.09 per share in fiscal Q2 2025, compared with a loss of CA$1.36 a year earlier.
Diluted earnings per share by quarter
| Quarter | Reported | EPS (diluted) | A year earlier | Change |
|---|---|---|---|---|
| Q2 FY2025ended Jun 30, 2025 | — | −CA$0.09 | −CA$1.36 | — |
| Q2 FY2024ended Jun 30, 2024 | — | −CA$1.36 | −CA$0.26 | — |
| Q2 FY2023ended Jun 30, 2023 | — | −CA$0.26 | −CA$3.12 | — |
| Q2 FY2022ended Jun 30, 2022 | — | −CA$3.12 | −CA$0.23 | — |
| Q2 FY2021ended Jun 30, 2021 | — | −CA$0.23 | — | — |
Company profile
- Name
- IM Cannabis Corp.
- Ticker
- IMCC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Medicinal Chemicals & Botanical Products
- Headquarters
- Kibbutz Glil Yam, Central District, L3 4690500
- Incorporated in
- A1
- Fiscal year ends
- December
- SEC CIK
- 0001792030
Recent SEC filings
- Mar 30, 2026
- Mar 31, 2025
- Sep 19, 2024
- Mar 28, 2024
- Mar 29, 2023
- Apr 4, 2022
- May 19, 2021
- Apr 26, 2021
Related stocks
IM Cannabis's industry, as the SEC classifies it, is Medicinal Chemicals & Botanical Products. The companies in it closest to IM Cannabis in revenue are Canopy Growth, Aurora Cannabis and SNDL.
Frequently asked questions
What is IM Cannabis's stock price?
IM Cannabis (IMCC) closed at $491.47 on Oct 9, 2026, down 0.70% from the previous close of $494.95.
How much revenue does IM Cannabis make?
IM Cannabis reported revenue of CA$54.73M for fiscal 2025, up 1.30% from fiscal 2024.
Sources and methodology
Fundamentals come from IM Cannabis Corp.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures